Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

A honey energy product is being recalled for containing an undeclared ingredient used for erectile dysfunction treatment.

The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction ...

Low libido is a lack of sexual desire or interest. Orgasmic disorders cause difficulty achieving orgasm, even with enough arousal. Sexual arousal disorder includes problems with getting or staying ...

In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...

There are four main causes of ED: psychogenic, vascular, hormonal and neurologic.

An experimental therapy known as low-intensity shock wave treatment might improve erectile dysfunction, particularly for men with only mild to moderate sexual difficulties, a research review suggests.

FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has secured a US notice of allowance for a continuation patent covering its ...

Cancer patients and survivors often experience difficulties with intimacy and sex, but many are reluctant to discuss the issue with their doctors, health experts say. But if left unaddressed, these ...

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...